We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$1.91B +$1.76B +23,951,677 New
Jennison Associates
2
Jennison Associates
New York
$1.37B +$1.27B +17,199,021 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$1.07B +$983M +13,343,982 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$924M +$852M +11,566,986 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$772M +$712M +9,662,642 New
State Street
6
State Street
Massachusetts
$565M +$521M +7,078,761 New
BFA
7
BlackRock Fund Advisors
California
$557M +$512M +6,953,275 New
JP Morgan Chase
8
JP Morgan Chase
New York
$551M +$506M +6,877,489 New
Goldman Sachs
9
Goldman Sachs
New York
$540M +$497M +6,745,175 New
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$526M +$485M +6,584,162 New
BIT
11
BlackRock Institutional Trust
California
$467M +$430M +5,836,143 New
ClearBridge Investments
12
ClearBridge Investments
New York
$449M +$413M +5,602,810 New
JHIU
13
Janus Henderson Investors US
Colorado
$406M +$375M +5,086,735 New
Ameriprise
14
Ameriprise
Minnesota
$366M +$337M +4,582,490 New
Lazard Asset Management
15
Lazard Asset Management
New York
$292M +$269M +3,650,067 New
O
16
OppenheimerFunds
New York
$284M +$262M +3,559,607 New
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$246M +$226M +3,071,274 New
WRF
18
Waddell & Reed Financial
Kansas
$233M +$214M +2,911,100 New
Invesco
19
Invesco
Georgia
$230M +$211M +2,869,371 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$214M +$197M +2,672,416 New
SAM
21
Sectoral Asset Management
Quebec, Canada
$202M +$186M +2,526,014 New
GVI
22
Green Valley Investors
Delaware
$200M +$184M +2,500,000 New
AllianceBernstein
23
AllianceBernstein
Tennessee
$198M +$183M +2,480,855 New
Northern Trust
24
Northern Trust
Illinois
$187M +$172M +2,332,435 New
Neuberger Berman Group
25
Neuberger Berman Group
New York
$168M +$155M +2,102,384 New
1
2 3 4 5

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.